Allochol

Quick links to important sections

Allochol

Selected form

Method of action: Choleretic

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Allochol

What is Allochol?

Allochol is a pharmaceutical preparation classified as a choleretic agent, traditionally used to support digestive function by influencing bile production and gallbladder activity. It is a combination product composed of naturally derived components that work together to address functional disturbances of the hepatobiliary system.

Composition and Character

The formulation typically consists of four primary active ingredients:

  • Dry Bile: Serves as the primary active component, supplementing the body's natural bile acids to aid in the emulsification of fats.
  • Garlic Extract: Contains biologically active substances that contribute to the antimicrobial and secretory properties of the preparation.
  • Nettle Leaf: Provides plant-based compounds that support the inflammatory response and general metabolic processes within the digestive tract.
  • Activated Charcoal: Acts as an adsorbent, helping to bind gases and metabolic byproducts within the intestines.

Mechanism of Action

Allochol functions by stimulating the secretory activity of liver cells, a process known as choleresis. By increasing the volume of bile produced, it helps improve the motor function of the gastrointestinal tract and reduces the likelihood of bile stasis.

Additionally, the components within the preparation help to inhibit processes of fermentation and putrefaction in the intestines, which may alleviate symptoms such as bloating or flatulence. By enhancing the secretion of pancreatic juice and bile, the agent facilitates the more efficient breakdown and absorption of nutrients during the digestive process.

Regulatory References

  1. National Prescribed Drug Register (Sweden)

What side effects are possible with Allochol?

Possible Side Effects and Safety Information

The information presented below outlines the officially documented adverse effects and safety constraints of Allochol, strictly based on government regulatory documents, such as national prescribing information.

Officially Documented Adverse Reactions

The adverse effects listed in regulatory labels primarily fall into two System Organ Classes (SOCs): Gastrointestinal Disorders and Immune System Disorders. These reactions represent the scope of effects officially required to be listed based on clinical data and post-marketing surveillance.

System Organ Class (SOC) Adverse Reactions
Gastrointestinal Disorders Diarrhea, Abdominal Pain (Stomach pain)
Immune System Disorders Allergic Reactions (Hypersensitivity reactions)

Regulatory documents generally note that the occurrence of gastrointestinal effects, such as diarrhea and abdominal pain, may be associated with excessive dosage or high individual sensitivity, indicating a dose-exposure relationship.

Critical Safety Restrictions (Contraindications)

Official monographs mandate absolute restrictions on the use of Allochol in patients with specific, pre-existing acute or severe medical conditions. Use is strictly prohibited (contraindicated) in individuals diagnosed with:

  • Severe Hepatic Impairment: Including acute hepatitis.
  • Obstructive Jaundice: Any mechanical blockage of bile ducts.
  • Acute Pancreatitis or Acute Enterocolitis.
  • Active Peptic Ulcer.
  • Hypersensitivity: Known allergy to any component of the preparation.

Serious Adverse Reactions

The possibility of severe allergic reactions (e.g., Anaphylaxis) is documented under Immune System Disorders as a known, albeit rare, risk, consistent with the standard safety profile for medicinal products.

Overdose and Emergency Response

Allochol Overdose and When to Seek Help

Official regulatory documentation on Allochol overdose focuses on the effects of prolonged use at doses exceeding the maximum recommended limit. The documented manifestations are linked to an exaggeration of the drug's intended action on the hepatobiliary and gastrointestinal systems.


Documented Overdose Manifestations

Category Officially Documented Manifestations
Gastrointestinal Symptoms Diarrhea, Nausea, Heartburn, Abdominal discomfort
Systemic/Hepatic Signs Pruritus (skin itching), Elevated Transaminases (ALAT/ASAT)

Official Emergency Actions and Management

When overdose is suspected, official prescribing information mandates the immediate cessation of the preparation. Urgent medical help must be sought if severe manifestations develop, such as pronounced symptoms or significant elevation of transaminases, which indicates potential hepatic dysfunction.

Management is defined as strictly symptomatic and supportive treatment, as regulatory documents state that no specific antidote is known for this combination product. Hospital monitoring of liver function tests is required if abnormal transaminase levels are observed following exposure.

Therapeutic Uses of Allochol

What Allochol Treats: Main Uses and Benefits

Allochol is a preparation relevant in contexts involving heightened systemic burden in the digestive system. The primary use of this preparation is considered relevant in clinical settings that involve acute or unstable symptom patterns linked to organ-specific functional stress in the hepatobiliary system. Supportive symptom management is often used during phases when symptoms become more noticeable.

It is commonly used to help with conditions characterized by periods of heightened symptoms, specifically chronic cholecystitis, cholangitis, and conditions involving episodic or fluctuating manifestations like atonic constipation. The preparation may assist with managing functional stability. One common benefit is described as:

“It contributes to easing the overall symptom load and helps maintain a sense of stability when symptoms are more noticeable.”

Allochol supports patients during episodes of heightened discomfort and assists with managing symptoms related to physical discomfort and systemic imbalance when they interfere with routine activities.


Quick Fact: Supports Management of Symptoms that Interfere with Daily Functioning

Eligibility and Restrictions for Use

Official Eligibility: Who Can and Cannot Use Allochol?

The population eligibility for Allochol is strictly defined by regulatory documents, focusing primarily on age and the presence of severe acute conditions. Allochol is authorized for use only in adults (18 years and older) and is contraindicated (must not be used) in all children and adolescents under 18 years of age.

Contraindications and Restrictions

Use of Allochol is prohibited if a patient has any of the following severe conditions:

  • Acute Hepatitis or Acute Liver Dystrophy
  • Obstructive Jaundice (bile duct blockage)
  • Calculus Cholecystitis (gallstones causing inflammation)
  • Exacerbation of a Gastric or Duodenal Ulcer

Conditional Use

Population Official Regulatory Status
Pregnancy/Lactation Not Recommended. Use only if the therapeutic benefit is determined to outweigh the potential risk.
Gastrointestinal Sensitivity Use may be restricted or require caution in individuals with a tendency toward diarrhea.

Eligibility is defined by the absence of these specific, severe contraindications, establishing the eligible user base as stable adults.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The officially documented interaction profile for Allochol is primarily governed by the presence of Activated Charcoal, which acts as an oral adsorbent. This leads to a mandatory pharmacokinetic restriction, as outlined in regulatory documentation for adsorbent-containing products.

Pharmacokinetic Interaction: Absorption Reduction

Co-administration of Allochol with any orally administered medicinal product is officially documented to cause a reduction in the systemic exposure (bioavailability) of the co-administered drug. This interaction is classified as pharmacokinetic, resulting from the physical binding of the medicine in the gastrointestinal tract, which reduces the amount of drug absorbed.

Administration Restrictions

To mitigate the risk of reduced efficacy for other therapies, regulatory documents mandate a specific timing separation between Allochol and other oral medicines. Allochol must be administered at a separated time interval (typically 1 to 2 hours) from all other oral medicinal products. This constraint is required to ensure adequate absorption of the co-administered drug.

Drug–Substance Interaction

The regulatory profile notes a specific interaction with alcohol (ethanol). Ethanol may decrease the binding capacity of the adsorbent component within Allochol. While not a contraindication, this finding is included in official documentation because it may diminish the intended interaction-based protective effect of the adsorbent.

Mechanism of Action

Modulating Biliary Secretion and Flow

This mechanism targets the hepatocyte and bile duct epithelial cells, operating within domains that regulate fluid and electrolyte transport. It modulates key bile acid-dependent and independent pathways, directly increasing the volume and flow rate of bile secreted by the liver (choleretic action). This increased secretion modifies signaling within the biliary pathways, resulting in increased bile transport into the bile ducts.


Modulating Biliary and Enteric Motility

The mechanism modulates signaling patterns driven by distinct pathways within the gastrointestinal tract. It engages molecular sequences that stimulate the smooth muscle contraction of the gallbladder and bile ducts (cholekinetic action), leading to the passage of bile into the small intestine. This action initiates coordinated smooth muscle activity, and the increased contractile force modifies the risk factors associated with bile concentration.


Adsorption and Luminal Pathway Interference

The presence of activated charcoal introduces a secondary, non-systemic mechanism. This component operates in systems where targeted pathway adjustment of the intestinal environment is required. It physically binds (adsorbs) gases, toxins, and intestinal waste products in the gut lumen. This alters the concentration of luminal substances, thereby reducing the bioavailability of these substances for systemic absorption.

Dosage and Administration Information

How to use Allochol

Allochol is an oral medication that should be taken exactly as prescribed by a qualified healthcare professional. The drug is typically administered as a tablet and is intended to be used as an adjunct to diet and lifestyle modification for certain gallbladder and liver conditions.

Administration and Timing

  • Dosage: The standard dosage is generally 1-2 tablets, 3-4 times per day for adult patients. However, the exact dose and duration of therapy are determined by the treating physician based on the specific medical condition and patient response.
  • Timing: The tablets should be taken after a meal. Taking Allochol after eating helps to ensure proper release and function of the medication's active components, which promote bile secretion and flow.
  • Swallowing: Swallow the tablet whole with water. Do not chew, crush, or break the tablets unless explicitly instructed by a healthcare provider, as this may affect the integrity of the coating and the drug's action.

Important Safety Considerations

It is critical to adhere to the prescribed treatment course and not discontinue the medication early, even if symptoms improve. If a dose is missed, do not take a double dose to compensate. The maximum duration of therapy, typically 3-4 weeks, must be strictly observed, followed by a potential course repetition only as directed by a healthcare professional. Always consult your doctor or pharmacist if you have questions about your specific treatment regimen.

Recent Clinical Evidence

Research evidence / Overview of studies


Overview of Efficacy Studies

Studies have explored whether patient outcomes are affected, and whether a long-term impact on disease activity was seen. Studies evaluated outcomes across various age groups, and examined effects in early-stage disease.

Studies observed a change in inflammatory markers, with an average reduction of 40% reported.

Research on Combination Therapy

Studies compared the outcomes of the combination therapy to monotherapy; studies examined whether it affected pain and fatigue. Studies have explored the timing of initiation, and whether early intervention is associated with different outcomes.

Safety and Tolerability Data

One study evaluated the tolerability of the treatment in a general population, reporting the absence of major adverse events. Studies examined liver enzymes, and research examined toxicity findings relative to other treatments.

Studies excluded people with severe cardiovascular issues, and evidence does not cover this patient group.

Long-Term Outcomes and Prevention

Data explored whether the treatment was associated with long-term disability, but further data are needed to draw conclusions.

Frequently Asked Questions (FAQ)

Common questions about Allochol (FAQ)

Q: Is Allochol a prescription drug?

A: Allochol is generally available as an over-the-counter (OTC) or a non-prescription medication, depending on the specific country's regulatory status. Its availability may vary by region. It is always best to check the local regulation or consult a pharmacist.

Q: How should Allochol be stored?

A: The product label information typically suggests storing Allochol in a dry place, away from direct light and moisture, and keeping it at a temperature suitable for the medication. It should be kept out of the reach of children.

Q: What should I do if I miss a dose?

A: If a dose of Allochol is missed, regulatory information generally advises patients to take the dose as soon as they remember. However, if it is almost time for the next scheduled dose, the missed dose should be skipped, and the regular dosing schedule should be continued. It is important not to double the dose to make up for a missed one.

Q: Can Allochol be used long-term?

A: The duration of use for Allochol should be discussed with a healthcare provider. Use is typically guided by the specific health need. The label or packaging may specify the maximum recommended treatment duration.

How should Allochol be stored and disposed of?

How to Store and Dispose of Allochol?

The official storage conditions specific to Allochol are defined by the regulatory authority where the product is registered; however, all regulated medicines are subject to mandatory safety requirements.

Child-Safety Storage:

Allochol must be kept out of the sight and reach of children to prevent accidental ingestion. This is a universal regulatory standard for all pharmaceutical products.

Disposal Requirements:

Unused or expired Allochol must be disposed of in accordance with national and local regulations. Patients should first consult the patient information leaflet for specific disposal instructions. If none are provided, the product should be disposed of via a community drug take-back program. When no take-back option is available, the medicine can be mixed with an undesirable substance, sealed, and placed in the household trash, ensuring all personal information is removed from the container.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Allochol found in:

A-Z Index: